Full-Time

P&L Valuations Associate

Posted on 11/26/2024

Schonfeld

Schonfeld

201-500 employees

Multi-manager investment platform for diverse strategies

Quantitative Finance
Financial Services

Compensation Overview

$110k - $130kAnnually

+ Performance Bonus + Competitive Benefits Package

Mid, Senior

New York, NY, USA

Category
Cost Accounting
Financial Analysis
Accounting
Required Skills
Data Analysis
Excel/Numbers/Sheets

You match the following Schonfeld's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • A Bachelor’s degree with 3-5 years of experience in P&L Reporting/Product Control
  • Strong knowledge of Listed Products and understanding of vanilla options
  • Experience in analyzing and reporting on P&L
  • Knowledge of Corporate Actions and their impact on P&L
  • Advanced Excel skills
  • Self-starter with a strong work ethic
  • Excellent verbal and written communication skills
  • Strong ownership and a track record of delivering results
  • The ability to handle a high volume of data in a fast-paced environment with strong attention to detail
Responsibilities
  • Work closely with the firm’s in-house Geneva system and Fund Administrator to ensure the accuracy of the enterprise P&L at Schonfeld
  • Overseeing pricing and P&L processes
  • Setup of new products
  • Liaise closely with global departments across the firm to ensure accurate T+1 and Monthly P&L reporting
Desired Qualifications
  • VBA knowledge
  • OTC Derivative knowledge
  • Experience with Bloomberg
  • Experience with Geneva

Schonfeld Strategic Advisors is a multi-manager investment platform that invests capital with internal and partner portfolio managers across four main strategies: quantitative, fundamental equity, tactical trading, and discretionary macro & fixed income. The firm provides portfolio managers with the autonomy and support needed to enhance their operations while leveraging proprietary technology and risk analytics to identify market opportunities. With a global presence covering the Americas, Europe, and Asia, Schonfeld serves institutional investors and high-net-worth individuals seeking diversified investment strategies. The company's goal is to generate returns through strategic investments and effective risk management.

Company Size

201-500

Company Stage

N/A

Total Funding

$1.5B

Headquarters

New York City, New York

Founded

1988

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven trading enhances Schonfeld's quantitative strategies and risk analytics.
  • Thematic ETFs in tech and healthcare offer high-growth investment opportunities for Schonfeld.
  • Alternative data integration provides Schonfeld competitive advantages in market insights.

What critics are saying

  • Departure of key Asia personnel may disrupt regional operations and growth.
  • New stakes in various companies expose Schonfeld to market volatility and sector risks.
  • New CTO appointment may lead to strategic shifts impacting current operations.

What makes Schonfeld unique

  • Schonfeld invests in diverse strategies: quantitative, fundamental equity, tactical trading, and macro.
  • The firm leverages proprietary technology and risk analytics for market opportunities.
  • Schonfeld offers global exposure across Americas, Europe, and Asia with multiple asset classes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Professional Development Budget

Company News

My Pharma Editions
Oct 14th, 2024
Inventiva annonce un financement allant jusqu’à 348 millions d’euros afin d’avancer l’étude NATiV3 de Phase 3 dans la MASH | MyPharma Editions

Inventiva, société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite associée à un dysfonctionnement métabolique (« MASH ») et d’autres maladies avec un besoin médical non satisfait, annonce aujourd'hui un financement immédiat de 94,1 millions d’euros et jusqu'à 348 millions d'euros (l’ « Opération

ETF Daily News
Jul 7th, 2024
iShares Russell 1000 Value ETF (NYSEARCA:IWD) Shares Acquired by BNP Paribas Financial Markets

Schonfeld Strategic Advisors LLC acquired a new stake in iShares Russell 1000 Value ETF in the third quarter valued at approximately $2,917,000.

Defense World
Jul 3rd, 2024
6,076 Shares in Thomson Reuters Co. (NYSE:TRI) Acquired by MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH

Schonfeld Strategic Advisors LLC purchased a new stake in Thomson Reuters in the 3rd quarter valued at approximately $709,000.

Business Insider
May 7th, 2024
Schonfeld's Asia cohead is leaving the $10 billion firm's fast-growing outpost

In the five years To was there, this person noted, Schonfeld's Asia business expanded to Japan and Australia and nearly tripled its head count in the region.

Defense World
May 7th, 2024
Vicor Co. (NASDAQ:VICR) VP Sells $43,303.07 in Stock

Schonfeld Strategic Advisors LLC purchased a new stake in Vicor in the third quarter valued at about $760,000.

eFinancialCareers
Apr 17th, 2024
CTO of the nicest hedge fund takes an executive role at Schonfeld

Thomas DeBow has joined Schonfeld as CTO, having held the same role at Alphadyne for the past six years.

Slater Sentinel
Apr 8th, 2024
Instrumental Wealth LLC Boosts Stock Position in Wheels Up Experience Inc. (NYSE:UP)

Schonfeld Strategic Advisors LLC purchased a new stake in Wheels Up Experience in the 3rd quarter valued at $39,000.

Defense World
Apr 4th, 2024
Acacia Research Co. (NASDAQ:ACTG) Shares Sold by Ritholtz Wealth Management

Finally, Schonfeld Strategic Advisors LLC acquired a new stake in Acacia Research in the first quarter valued at approximately $49,000.

Defense World
Mar 28th, 2024
Short Interest in Patria Latin American Opportunity Acquisition Corp. (NASDAQ:PLAO) Expands By 1,500.0%

Schonfeld Strategic Advisors LLC acquired a new stake in Patria Latin American Opportunity Acquisition in the 1st quarter valued at about $158,000.

MarketBeat
Mar 25th, 2024
Brokerages Set Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Target Price at $57.71

Schonfeld Strategic Advisors LLC purchased a new stake in Arcturus Therapeutics in the 3rd quarter worth approximately $2,738,000.

INACTIVE